DONATE 314 • 786 • 5950
What the Cancer Community is saying about the difference the STLMGAC makes in the lives of those dealing with cancer
Cynthia Ma, M.D., Ph.D.1
SLMGAC funded research for Dr Ma’s Breast cancer research tissue collection and analysis program. This program aims to collect blood and tumor tissue samples from patients with metastatic breast cancer at Siteman for state-of-the-art genomic analysis as well as establishing patient derived breast cancer models in small, self-organized cell cultures in mice.
This research enabled Dr MA and her team to understand why some patients respond better than others and why some don’t respond. Doing DNA and RNA bio marker analysis, found that tumor cells are more infiltrated with immune cells and don’t respond to this therapy…these patients can be treated with immunotherapy.
Analysis of the NeoPalAna trial samples helped Dr MA understand why some patients do not benefit from CDK4/6 inhibitor and endocrine therapy drugs. As a result, Dr Ma identified potential new directions in developing effective therapies for resistant tumors. With NIH funding down, Dr Ma says that what the SLMGAC provides is essential for future new treatments.